NO20054296L - Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep - Google Patents

Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep

Info

Publication number: NO20054296L
Authority: NO; Norway
Prior art keywords: vomiting; palonosetron; treatment; nausea; surgery
Prior art date: 2003-02-18

Application number

NO20054296A

Other languages

English (en)

Norwegian (no)

Other versions

NO20054296D0 (no

Inventor

Alberto Macciocch

Ricardo Braglia

Enrico Braglia

Luigi Baroni

Original Assignee

Helsinn Healthcare Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-18

Filing date

2005-09-16

Publication date

2005-11-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32908576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054296(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-09-16 Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa

2005-09-16 Publication of NO20054296D0 publication Critical patent/NO20054296D0/no

2005-11-17 Publication of NO20054296L publication Critical patent/NO20054296L/no

Links

CPZBLNMUGSZIPR-NVXWUHKLSA-N palonosetron Chemical compound C1N(CC2)CCC2[C@@H]1N1C(=O)C(C=CC=C2CCC3)=C2[C@H]3C1 CPZBLNMUGSZIPR-NVXWUHKLSA-N 0.000 title abstract 2
229960002131 palonosetron Drugs 0.000 title abstract 2
206010047700 Vomiting Diseases 0.000 title 1
238000001356 surgical procedure Methods 0.000 title 1
208000031649 Postoperative Nausea and Vomiting Diseases 0.000 abstract 3
102000035037 5-HT3 receptors Human genes 0.000 abstract 1
108091005477 5-HT3 receptors Proteins 0.000 abstract 1
239000002895 emetic Substances 0.000 abstract 1
239000002464 receptor antagonist Substances 0.000 abstract 1
229940044551 receptor antagonist Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Hospice & Palliative Care (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20054296A 2003-02-18 2005-09-16 Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep NO20054296L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US44834203P	2003-02-18	2003-02-18
PCT/EP2004/001558 WO2004073714A1 (en)	2003-02-18	2004-02-18	Use of palonosetron treating post-operative nausea and vomiting

Publications (2)

Publication Number	Publication Date
NO20054296D0 NO20054296D0 (no)	2005-09-16
NO20054296L true NO20054296L (no)	2005-11-17

Family

ID=32908576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054296A NO20054296L (no)	2003-02-18	2005-09-16	Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep

Country Status (31)

Country	Link
US (1)	US20060074101A1 (es)
EP (2)	EP2258367A3 (es)
JP (1)	JP2006517944A (es)
KR (1)	KR101113087B1 (es)
CN (1)	CN1750822A (es)
AT (1)	ATE490774T1 (es)
AU (1)	AU2004212704B2 (es)
BR (1)	BRPI0407549A (es)
CA (1)	CA2515946C (es)
CU (1)	CU23587B7 (es)
CY (1)	CY1111312T1 (es)
DE (1)	DE602004030424D1 (es)
DK (1)	DK1596862T3 (es)
EA (1)	EA013836B1 (es)
EC (1)	ECSP055970A (es)
ES (1)	ES2357769T3 (es)
GE (1)	GEP20104908B (es)
HR (1)	HRP20050709A2 (es)
IS (1)	IS7983A (es)
MX (1)	MXPA05008757A (es)
MY (1)	MY143789A (es)
NO (1)	NO20054296L (es)
NZ (1)	NZ541862A (es)
PL (1)	PL378122A1 (es)
PT (1)	PT1596862E (es)
SI (1)	SI1596862T1 (es)
TW (1)	TWI355936B (es)
UA (1)	UA96254C2 (es)
UY (1)	UY28193A1 (es)
WO (1)	WO2004073714A1 (es)
ZA (1)	ZA200506580B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5690461B2 (ja) *	2002-11-15	2015-03-25	ヘルシンヘルスケアソシエテアノニム	化学療法誘導嘔吐を治療するためのパロノセトロン
US8598219B2 (en)	2003-01-30	2013-12-03	Helsinn Healthcare Sa	Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en)	2003-01-30	2013-09-15	هيلسين هيلث كير أس ايه.	Liquid pharmaceutical formulations of palonosetron
KR20140088230A (ko) *	2006-01-27	2014-07-09	앱탈리스 파마테크, 인코포레이티드	약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
NZ570039A (en) *	2006-01-27	2011-07-29	Eurand Inc	Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids
CA2666512C (en) *	2006-10-24	2014-05-27	Helsinn Healthcare S.A.	Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
TWI429436B (zh) *	2007-04-10	2014-03-11	Helsinn Therapeutics Us Inc	使用生長激素促泌素治療或預防嘔吐之方法
US20090155363A1 (en) *	2007-12-14	2009-06-18	Todd Maibach	Methods for oral administration of active drugs
WO2009139411A1 (ja)	2008-05-15	2009-11-19	久光製薬株式会社	パロノセトロンを含有する経皮吸収製剤
WO2010077669A2 (en) *	2008-12-08	2010-07-08	Teva Pharmaceutical Industries Ltd.	Palonosetron formulation
ES2664599T3 (es)	2009-05-20	2018-04-20	INSERM (Institut National de la Santé et de la Recherche Médicale)	Antagonistas del receptor 5-HT3 de serotonina para uso en el tratamiento de trastornos vestibulares lesionales
EP2253316B1 (en) *	2009-05-20	2013-08-14	INSERM (Institut National de la Santé et de la Recherche Médicale)	Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
US20110003005A1 (en) *	2009-07-06	2011-01-06	Gopi Venkatesh	Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
WO2011058427A1 (en)	2009-11-13	2011-05-19	Helsinn Healthcare S.A.	Palonosetron metabolites
EP2722045B1 (en)	2009-11-18	2016-07-06	Helsinn Healthcare SA	Compositions for treating centrally mediated nausea and vomiting
CN106512010A (zh)	2009-11-18	2017-03-22	赫尔辛医疗股份公司	用于治疗中枢介导的恶心及呕吐的组合物及方法
KR101368587B1 (ko) *	2010-12-27	2014-03-05	주식회사 삼양바이오팜	오심 또는 구토 방지용 조성물
WO2014004126A1 (en)	2012-06-26	2014-01-03	Fleming C Andrew	Treating postoperative nausea and vomiting
MX2016008369A (es)	2013-12-23	2016-12-15	Samyang Biopharmaceuticals	Composicion farmaceutica que incluye palonosetron.
HRP20240453T1 (hr)	2016-04-14	2024-06-21	Sensorion	(+)-azasetron za uporabu u liječenju poremećaja uha
JP6768404B2 (ja) *	2016-08-12	2020-10-14	武田テバファーマ株式会社	パロノセトロン又はその薬学的に許容される塩を含む医薬組成物
JP6705348B2 (ja) *	2016-09-23	2020-06-03	ニプロ株式会社	液体製剤、及び、パロノセトロンの安定性を向上する方法
GB201618425D0 (en) *	2016-11-01	2016-12-14	Acacia Pharma Ltd	method
KR101802183B1 (ko) *	2016-11-16	2017-11-28	주식회사 유영제약	팔로노세트론을 활성성분으로 함유하는 약제학적 조성물
GB201702250D0 (en)	2017-02-10	2017-03-29	Acacia Pharma Ltd	Method
FI3737378T3 (fi) *	2018-01-12	2023-06-02	Orion Corp	Palonosetronisilmätipat pahoinvoinnin ja oksentelun hoitoon tai ehkäisyyn
CN108703960A (zh) *	2018-07-25	2018-10-26	无锡鑫连鑫生物医药科技有限公司	一种帕洛诺司琼缓释微球及其制备方法和使用方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4695578A (en)	1984-01-25	1987-09-22	Glaxo Group Limited	1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
DE3650772T2 (de)	1985-04-27	2003-04-03	F. Hoffmann-La Roche Ag, Basel	Derivate von Indazole-3-carboxamide und -3-carboxylsäure
US4937247A (en)	1985-04-27	1990-06-26	Beecham Group P.L.C.	1-acyl indazoles
US5240954A (en)	1985-06-25	1993-08-31	Glaxo Group Limited	Medicaments
GB8516083D0 (en)	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
US5578628A (en)	1985-06-25	1996-11-26	Glaxo Group Limited	Medicaments for the treatment of nausea and vomiting
US4906755A (en)	1986-11-03	1990-03-06	Merrell Dow Pharmaceuticals Inc.	Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
US4707484A (en)	1986-11-25	1987-11-17	Hoffmann-La Roche Inc.	Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
US5011846A (en)	1988-02-23	1991-04-30	Merrell Dow Pharmaceuticals Inc.	Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US5344658A (en) *	1989-06-28	1994-09-06	Glaxo Group Limited	Process and composition using ondansetron
GB8914804D0 (en) *	1989-06-28	1989-08-16	Glaxo Group Ltd	Process
NZ236225A (en)	1989-11-28	1992-09-25	Syntex Inc	Azabicyclic-substituted isoquinoline derivatives, intermediates and pharmaceutical compositions
US5189041A (en)	1990-11-16	1993-02-23	Syntex (U.S.A.) Inc.	Tricyclic 5-ht3 receptor antagonists
US5137893A (en)	1991-03-07	1992-08-11	G. D. Searle & Co.	Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5491148A (en)	1991-04-26	1996-02-13	Syntex (U.S.A.) Inc.	Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists
US5272137A (en) *	1992-02-14	1993-12-21	Mcneil-Pfc, Inc.	Aqueous pharmaceutical suspension for pharmaceutical actives
GB9305593D0 (en)	1993-03-18	1993-05-05	Smithkline Beecham Plc	Pharmaceuticals
US5492914A (en)	1994-07-28	1996-02-20	Syntex (U.S.A.) Inc.	2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof
GB9423588D0 (en) *	1994-11-22	1995-01-11	Glaxo Wellcome Inc	Compositions
GB9423511D0 (en)	1994-11-22	1995-01-11	Glaxo Wellcome Inc	Compositions
GB9625589D0 (en) *	1996-12-10	1997-01-29	Boots Co Plc	Therapeutic agents
US20030095926A1 (en) *	1997-10-01	2003-05-22	Dugger Harry A.	Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US6294548B1 (en)	1998-05-04	2001-09-25	Hoffmann-La Roche Inc.	Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
AU4551499A (en) *	1998-06-08	1999-12-30	Advanced Medicine, Inc.	Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-HT3 receptors
AU753462B2 (en) *	1998-10-27	2002-10-17	Alcon Laboratories, Inc.	Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
US6196963B1 (en) *	1999-03-02	2001-03-06	Medtronic Ave, Inc.	Brachytherapy device assembly and method of use
AU2003237657A1 (en) *	2002-05-24	2003-12-12	Epidauros Biotechnologie Ag	Means and methods for improved treatment using "setrones"
JP5690461B2 (ja) *	2002-11-15	2015-03-25	ヘルシンヘルスケアソシエテアノニム	化学療法誘導嘔吐を治療するためのパロノセトロン
US8598219B2 (en) *	2003-01-30	2013-12-03	Helsinn Healthcare Sa	Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) *	2003-01-30	2013-09-15	هيلسين هيلث كير أس ايه.	Liquid pharmaceutical formulations of palonosetron

2004
- 2004-02-17 TW TW093103716A patent/TWI355936B/zh not_active IP Right Cessation
- 2004-02-17 MY MYPI20040515A patent/MY143789A/en unknown
- 2004-02-18 UY UY28193A patent/UY28193A1/es not_active Application Discontinuation
- 2004-02-18 NZ NZ541862A patent/NZ541862A/en not_active IP Right Cessation
- 2004-02-18 GE GEAP20048984A patent/GEP20104908B/en unknown
- 2004-02-18 ES ES04712041T patent/ES2357769T3/es not_active Expired - Lifetime
- 2004-02-18 MX MXPA05008757A patent/MXPA05008757A/es active IP Right Grant
- 2004-02-18 WO PCT/EP2004/001558 patent/WO2004073714A1/en not_active Ceased
- 2004-02-18 HR HR20050709A patent/HRP20050709A2/xx not_active Application Discontinuation
- 2004-02-18 KR KR1020057014589A patent/KR101113087B1/ko not_active Ceased
- 2004-02-18 DE DE602004030424T patent/DE602004030424D1/de not_active Expired - Lifetime
- 2004-02-18 BR BRPI0407549-8A patent/BRPI0407549A/pt not_active Application Discontinuation
- 2004-02-18 AU AU2004212704A patent/AU2004212704B2/en not_active Expired
- 2004-02-18 PL PL378122A patent/PL378122A1/pl not_active Application Discontinuation
- 2004-02-18 AT AT04712041T patent/ATE490774T1/de active
- 2004-02-18 CA CA002515946A patent/CA2515946C/en not_active Expired - Fee Related
- 2004-02-18 EP EP10177400A patent/EP2258367A3/en not_active Withdrawn
- 2004-02-18 CN CNA2004800045134A patent/CN1750822A/zh active Pending
- 2004-02-18 UA UAA200508834A patent/UA96254C2/uk unknown
- 2004-02-18 DK DK04712041.5T patent/DK1596862T3/da active
- 2004-02-18 SI SI200431601T patent/SI1596862T1/sl unknown
- 2004-02-18 EA EA200501318A patent/EA013836B1/ru not_active IP Right Cessation
- 2004-02-18 EP EP04712041A patent/EP1596862B1/en not_active Revoked
- 2004-02-18 PT PT04712041T patent/PT1596862E/pt unknown
- 2004-02-18 JP JP2006501881A patent/JP2006517944A/ja active Pending
2005
- 2005-08-10 US US11/201,035 patent/US20060074101A1/en not_active Abandoned
- 2005-08-15 IS IS7983A patent/IS7983A/is unknown
- 2005-08-17 ZA ZA200506580A patent/ZA200506580B/en unknown
- 2005-08-17 CU CU20050158A patent/CU23587B7/es active IP Right Grant
- 2005-08-18 EC EC2005005970A patent/ECSP055970A/es unknown
- 2005-09-16 NO NO20054296A patent/NO20054296L/no unknown
2011
- 2011-03-04 CY CY20111100257T patent/CY1111312T1/el unknown

Also Published As

Publication number	Publication date
UY28193A1 (es)	2004-09-30
NZ541862A (en)	2008-04-30
CA2515946C (en)	2008-12-02
NO20054296D0 (no)	2005-09-16
EA200501318A1 (ru)	2006-02-24
ATE490774T1 (de)	2010-12-15
PL378122A1 (pl)	2006-03-06
AU2004212704A1 (en)	2004-09-02
HRP20050709A2 (en)	2005-12-31
GEP20104908B (en)	2010-03-10
EP2258367A2 (en)	2010-12-08
KR101113087B1 (ko)	2012-02-15
IS7983A (is)	2005-08-15
DE602004030424D1 (de)	2011-01-20
CA2515946A1 (en)	2004-09-02
PT1596862E (pt)	2011-03-15
ES2357769T3 (es)	2011-04-29
BRPI0407549A (pt)	2006-02-14
ZA200506580B (en)	2006-06-28
EP2258367A3 (en)	2011-07-13
EP1596862B1 (en)	2010-12-08
MY143789A (en)	2011-07-15
ECSP055970A (es)	2006-01-16
US20060074101A1 (en)	2006-04-06
TW200418474A (en)	2004-10-01
EP1596862A1 (en)	2005-11-23
DK1596862T3 (da)	2011-03-28
SI1596862T1 (sl)	2011-03-31
AU2004212704B2 (en)	2009-10-01
WO2004073714A1 (en)	2004-09-02
MXPA05008757A (es)	2006-05-31
HK1076402A1 (en)	2006-01-20
TWI355936B (en)	2012-01-11
UA96254C2 (uk)	2011-10-25
EA013836B1 (ru)	2010-08-30
JP2006517944A (ja)	2006-08-03
CY1111312T1 (el)	2015-08-05
CU23587B7 (es)	2010-10-30
CN1750822A (zh)	2006-03-22
KR20050121671A (ko)	2005-12-27

Publication	Publication Date	Title
NO20054296D0 (no)	2005-09-16	Anvendelse av palonosetron for behandling av kvalme og oppkast etter kirurgisk inngrep
NO20073628L (no)	2007-07-16	Pyridoner som er nyttige som inhibitorer av kinaser
NO20080484L (no)	2008-03-28	Niacin-reseptorantagonister, preparater inneholdende slike forbindelser og behandlingsmetoder
GB0504828D0 (en)	2005-04-13	Therapeutic agents
NO20065417L (no)	2006-12-29	Muskarine acetylkolinreceptorantagonister
EP2520311A3 (en)	2012-11-14	Method of treating hemolytic disease
GB0426313D0 (en)	2005-01-05	Therapeutic agents
EA200800716A1 (ru)	2008-08-29	Новая кристаллическая форма производного пиридазино[4,5-в]индола
BRPI0512958A (pt)	2008-04-22	antagonistas de nk1
NO20063032L (no)	2006-08-30	Nye M3 muskarinacetylkolinreceptorantagoniser
MA27566A1 (fr)	2005-10-03	Inhibiteurs de 4-oxo-1-(3-phenyle substitue -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4
NO20061112L (no)	2006-05-12	Metode og apparat for kinematisk linking av multiple seismiske domener
NO20060775L (no)	2006-04-11	Muskarine acetylkolinreseptorantagonister
CA2505990A1 (en)	2004-06-03	Palonosetron for the treatment of chemotherapy-induced emesis
NO20063636L (no)	2006-10-04	Muskariniske acetylkolinrecptoorantagonister
NO20072832L (no)	2007-08-01	Smertestillende middel
MX2007005428A (es)	2007-05-18	Combinaciones de agonistas del receptor nicotinico alfa 7 y de la acetilcolina.
PL1831152T3 (pl)	2009-03-31	Pochodne tetraliny i indanu oraz ich zastosowanie jako antagonistów 5-HT
NO20083269L (no)	2008-09-19	Prosess for a anvende krystallinsk orlistatmetoder
SE0103795D0 (sv)	2001-11-02	Compounds and method for the treatment of överactive bladder
SE0203410D0 (sv)	2002-11-18	New use
DE60102231D1 (de)	2004-04-08	Crf rezeptor-antagonisten und darauf bezogene methoden
MY136854A (en)	2008-11-28	Crystalline n-formyl hydroxylamine compounds
MX2007007485A (es)	2007-07-20	Derivados de cromano y usos de los mismos en el tratamiento de trastornos del sistema nervioso central.
MXPA04004071A (es)	2004-09-06	Metodo para tratamiento de vejiga hiperactiva.